Neumora Therapeutics, Inc.
NMRA-335140
Major Depressive Disorder
Countdown
358days
Phase 3 readout · ~ Jun 30, 2027 estimated
What's at stake
Phase 3 trial results for NMRA-335140 in Major Depressive Disorder are due ~ Jun 30, 2027. A clean hit validates the program; a miss can gap the stock down hard.
Primary source
· ClinicalTrials.gov
verified 15h ago
“CT.gov NCT06029439: Phase 3 trial, sponsor Neumora Therapeutics, Inc., drug NMRA-335140. Primary completion date 2027-06 (estimated).”